| __timestamp | Catalyst Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 1213000 |
| Thursday, January 1, 2015 | 8597010 | 3425000 |
| Friday, January 1, 2016 | 7910260 | 6311000 |
| Sunday, January 1, 2017 | 7304399 | 9518000 |
| Monday, January 1, 2018 | 15875961 | 28080000 |
| Tuesday, January 1, 2019 | 36881187 | 36550000 |
| Wednesday, January 1, 2020 | 44233754 | 46125000 |
| Friday, January 1, 2021 | 49628000 | 68486000 |
| Saturday, January 1, 2022 | 58183000 | 92032000 |
| Sunday, January 1, 2023 | 133710000 | 117532000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Catalyst Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc. have shown distinct trajectories in their SG&A spending.
Catalyst Pharmaceuticals has seen a remarkable increase in SG&A expenses, growing by approximately 2,900% from 2014 to 2023. This surge reflects strategic investments in marketing and administrative capabilities, crucial for sustaining growth in a competitive market.
Rhythm Pharmaceuticals, on the other hand, has experienced a more moderate increase of around 9,600% over the same period. This indicates a balanced approach, focusing on efficient resource allocation while expanding their market presence.
Both companies demonstrate unique strategies in managing SG&A expenses, highlighting the diverse approaches within the pharmaceutical industry.
Gilead Sciences, Inc. vs Rhythm Pharmaceuticals, Inc.: SG&A Expense Trends
Biogen Inc. and Rhythm Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Sarepta Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Ionis Pharmaceuticals, Inc. or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Rhythm Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Xencor, Inc. Trends and Insights